Pacira Pharmaceuticals Announces Favorable Resolution With U.S. Food and Drug Administration, Which Reaffirms the Broad Indication for EXPAREL®
15 déc. 2015 00h01 HE
|
Pacira Pharmaceuticals, Inc.
-- Terms Include Labeling Changes to Reinforce that the Use of EXPAREL is not Limited to Pivotal Trial Surgical Models, and Formal FDA Rescission of 2014 Warning Letter – -- Conference Call Today...
Pacira Pharmaceuticals, Inc. to Present at the 27th Annual Piper Jaffray Healthcare Conference
24 nov. 2015 07h30 HE
|
Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Nov. 24, 2015 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that Dave Stack, chief executive officer and chairman of Pacira Pharmaceuticals, is...
New Survey Sheds Light on Prescription Drug Use Among Women After Surgery in the United States
17 nov. 2015 07h30 HE
|
Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Nov. 17, 2015 (GLOBE NEWSWIRE) -- One in every 15 patients who receive prescription painkillers (also called opioids or narcotics) following surgery ends up using these...
Pacira Pharmaceuticals, Inc. to Present at the Jefferies Autumn 2015 Global Healthcare Conference
11 nov. 2015 07h30 HE
|
Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Nov. 11, 2015 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that Jim Scibetta, president and chief financial officer of Pacira Pharmaceuticals,...
New Study Finds Decreased Opioid Use, Hospital Stay and Readmission Rates With EXPAREL Following Knee Replacement Surgery
06 nov. 2015 16h30 HE
|
Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Nov. 06, 2015 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced positive data on the use of EXPAREL® (bupivacaine liposome injectable suspension) as a...
Pacira Pharmaceuticals, Inc. Reports Third Quarter 2015 Financial Results
27 oct. 2015 07h30 HE
|
Pacira Pharmaceuticals, Inc.
-- Total Revenues of $62.2 Million in Third Quarter -- -- EXPAREL® Net Revenues of $59.7 Million in Third Quarter -- -- Conference Call Today at 9 a.m. ET -- PARSIPPANY, N.J., Oct. 27, 2015 ...
Pacira Pharmaceuticals Announces the Promotion of James S. Scibetta to President
20 oct. 2015 07h30 HE
|
Pacira Pharmaceuticals, Inc.
-- Dave Stack Remains Chairman and Chief Executive Officer; Continues to Drive Commercial Strategy and Clinical Development of EXPAREL® and the DepoFoam® Pipeline -- -- Mr. Scibetta to Lead...
Pacira Pharmaceuticals Announces Timing for Third Quarter 2015 Financial Results Webcast and Conference Call
13 oct. 2015 07h30 HE
|
Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Oct. 13, 2015 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced that financial results for the company’s third quarter ended September 30, 2015...
Pacira Pharmaceuticals, Inc. Webcast Replay of 2013 Financial Results Conference Call
25 févr. 2014 15h35 HE
|
Pacira Pharmaceuticals, Inc.
PARSIPPANY, N.J., Feb. 25, 2014 (GLOBE NEWSWIRE) -- Pacira Pharmaceuticals, Inc. (Nasdaq:PCRX) today announced that a replay of the company's fourth quarter and full-year 2013 financial results...